Pancreatic Cancer: Updates in Clinical Diagnosis, Epidemiology, Treatment, and Outcomes
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Oncology".
Deadline for manuscript submissions: 20 February 2025 | Viewed by 28
Special Issue Editors
Interests: bacterial pathogenesis; pancreatic cancer; vaccine and drug development
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pancreatic cancer remains a formidable challenge in oncology due to its aggressive nature and poor prognosis. Recent advancements in clinical diagnosis have focused on early detection through improved imaging techniques and biomarkers, aiming to identify the disease at a more treatable stage. The epidemiology of pancreatic cancer has shown increasing incidence rates globally, with risk factors such as smoking, obesity, diabetes, and chronic pancreatitis being significant contributors. Treatment strategies have evolved through the integration of precision medicine and the utilization of genetic and molecular profiling to tailor therapies. Surgical resection remains the cornerstone of potentially curative treatment, often supplemented by neoadjuvant and adjuvant therapies. Advances in chemotherapy and the advent of immunotherapy are offering new hope, although their impacts on survival rates are still under study. Despite these efforts, the overall outcomes for pancreatic cancer patients remain dismal, underscoring the need for ongoing research and innovative therapeutic approaches.
We invite you and your colleagues to submit articles on this topic. All types of manuscripts are welcome, including original research articles, reviews (narrative and systematic with/without meta-analysis), and case reports.
Dr. Vikas Kumar Somani
Dr. Naoshad Muhammad
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pancreatic cancer
- early detection
- biomarkers
- epidemiology
- risk factors
- precision medicine
- surgical resection
- chemotherapy
- immunotherapy
- patient outcomes
- targeted therapy
